La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Odonate Inc a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Odonate Inc..

Odonate Inc (OTC:ODTCD) Azioni, Catena delle Opzioni

Odonate Inc

News

Cardinal Health Announced The U.S. Launch Of Its Kendall SCD SmartFlow Compression System, The Next Generation Of The Kendall Compression Series Offering An Enhanced Clinician And Patient Experience

JP Morgan analyst Alexei Gogolev maintains Wix.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WIX#NASDAQ">WIX</a>) with a Neutral and raises the price target from $195 to $205.

Price Target

Analyst Ratings

JP Morgan Maintains Neutral on Wix.com, Raises Price Target to $205

The most oversold stocks in the industrials sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the<a href="https://www.benzinga.com/topic/rsi"> RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">BingEx Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLX#NASDAQ">FLX</a>)</h3>
<ul>
<li>On Oct. 4, BingEx announced the pricing of $66 million initial public offering of 4 million ADSs at a price of $16.50 per ADS. The company's stock fell around 40% over the past month and has a <a href="https://www.benzinga.com/quote/FLX">52-week low of $8.04</a>.</li>
<li>RSI Value: 27.38&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>FLX Price Action: Shares of BingEx fell 1.5% to close at $8.71 on Tuesday.</li>
<li>Benzinga Pro's real-time newsfeed alerted to <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent112024&amp;t=be2bearmibe3na1">latest FLX news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent112024&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="922" height="382" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/20033648/image-200.png" alt="" class="wp-image-656482" style="width:577px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/20033648/image-200.png 922w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/20033648/image-200-300x124.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/20033648/image-200-768x318.png 768w" sizes="(max-width: 922px) 100vw, 922px" /></a></figure>
<h3 class="wp-block-heading">Brinks Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BCO#NYSE">BCO</a>)&nbsp;&nbsp;&nbsp;&nbsp;</h3>
<ul>
<li>On Nov. 6, Brink&#8217;s posted weaker-than-expected quarterly results. The company's stock fell around 14% over the past month and <a href="https://www.benzinga.com/quote/BCO">has a 52-week low </a> of $76.93.</li>
<li>RSI Value: 25.00</li>
<li>BCO Price Action: Shares of Brinks gained 0.5% to close at $91.76 on Tuesday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the trend in <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent112024&amp;t=be2bearmibe3na1">BCO stock</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent112024&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="912" height="827" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/20033753/image-201.png" alt="" class="wp-image-656483" style="width:651px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/20033753/image-201.png 912w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/20033753/image-201-300x272.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/20033753/image-201-768x696.png 768w" sizes="(max-width: 912px) 100vw, 912px" /></a></figure>
<h3 class="wp-block-heading">KBR Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KBR#NYSE">KBR</a>)</h3>
<ul>
<li>On Oct. 23, KBR posted in-line quarterly earnings. &#8220;KBR&#8217;s exceptional team has once again exceeded expectations with outstanding third-quarter results,&#8221; stated Stuart Bradie, KBR&#8217;s President and CEO. The company's stock fell around 17% over the past five days and has a 52-week <a href="https://www.benzinga.com/quote/KBR">low of $50.45</a>.</li>
<li>RSI Value: 27.09</li>
<li>KBR Price Action: Shares of KBR gained 0.2% to close at $58.29 on Tuesday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent112024&amp;t=be2bearmibe3na1">breakout in KBR shares</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent112024&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="790" height="562" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/20033855/image-202.png" alt="" class="wp-image-656487" style="width:631px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/20033855/image-202.png 790w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/20033855/image-202-300x213.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/20033855/image-202-768x546.png 768w" sizes="(max-width: 790px) 100vw, 790px" /></a></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/24/11/42069785/wall-streets-most-accurate-analysts-weigh-in-on-3-defensive-stocks-with-over-5-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Weigh In On 3 Defensive Stocks With Over 5% Dividend Yields</a></li>
</ul>

Long Ideas

Pre-Market Outlook

Markets

Trading Ideas

Top 3 Industrials Stocks That Are Preparing To Pump In November

AVTR

Quantum-Si Announced A Distribution Agreement With Avantor

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/59282ae7290fa70001853260/samantha-hoh">HSBC analyst Samantha Hoh</a> downgraded the rating for Bloom Energy Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BE#NYSE">BE</a>) from Buy to Hold and announced a $24.5 price target. Bloom Energy shares closed at $23.75 on Tuesday. <a href="https://www.benzinga.com/quote/BE/analyst-ratings">See how other analysts view this stock.</a></li>
<li>RBC Capital analyst Scott Hanold downgraded Northern Oil and Gas, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOG#NYSE">NOG</a>) from Outperform to Sector Perform but raised the price target from $43 to $45. Northern Oil &amp; Gas shares closed at $41.08 on Tuesday. <a href="https://www.benzinga.com/quote/NOG/analyst-ratings">See how other analysts view this stock.</a></li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/611252c2b4035700018aa3b5/thomas-poutrieux">Exane BNP Paribas analyst Thomas Poutrieux</a> downgraded the rating for Toast, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TOST#NYSE">TOST</a>) from Outperform to Neutral and announced a $37 price target. Toast shares closed at $42.50 on Tuesday. <a href="https://www.benzinga.com/quote/TOST/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JP Morgan analyst Melissa Wedel downgraded Oaktree Specialty Lending Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCSL#NASDAQ">OCSL</a>) from Overweight to Neutral and cut the price target from $17 to $15. Oaktree Specialty Lending shares closed at $15.61 on Tuesday. <a href="https://www.benzinga.com/quote/OCSL/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Exane BNP Paribas analyst Alex Faure downgraded the rating for Block, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SQ#NYSE">SQ</a>) from Outperform to Neutral and announced a price target of $88. Block shares closed at $92.42 on Tuesday. <a href="https://www.benzinga.com/quote/SQ/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying SQ stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="582" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/20073503/image-207-1024x582.png" alt="" class="wp-image-656791" style="width:646px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/20073503/image-207-1024x582.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/20073503/image-207-300x170.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/20073503/image-207-768x436.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/20073503/image-207.png 1181w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/24/11/42069785/wall-streets-most-accurate-analysts-weigh-in-on-3-defensive-stocks-with-over-5-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Weigh In On 3 Defensive Stocks With Over 5% Dividend Yields</a></li>
</ul>

Downgrades

OCSL

TOST

This Block Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

Baird analyst Richard Eastman maintains Keysight Techs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KEYS#NYSE">KEYS</a>) with a Outperform and raises the price target from $163 to $180.

KEYS

Baird Maintains Outperform on Keysight Techs, Raises Price Target to $180

Health Care

Contracts

General

Quantum-Si Announced A Distribution Agreement With Avantor To Distribute Quantum-Si's Next-generation Protein Sequencing Portfolio To Researchers Across All Market Segments In Us And Canada

UHAL

U-haul Stated That It Is Now Operating At A New Self-storage Location In Biloxi, Offering A Variety Of 344 Indoor Climate-controlled Units For Rent At 12011 Old Highway 67

Baird analyst Andrew Wittmann maintains Jacobs Solutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/J#NYSE">J</a>) with a Outperform and raises the price target from $147 to $149.

Baird Maintains Outperform on Jacobs Solutions, Raises Price Target to $149

OCGN

Ocugen Announced That The European Medicines Agency Has Granted Orphan Medicinal Product Designation For OCU410ST For The Treatment Of Abca4-associated Retinopathies Including Stargardt Disease, Retinitis Pigmentosa 19, And Cone-rod Dystrophy 3

23andMe And Mirador Therapeutics Announced A Strategic Research Collaboration. Under The Agreement, Mirador Will Leverage A Targeted Set Of Aggregated, De-Identified Genetic And Phenotypic Data From The 23andMe Research Database And Its Proprietary Mirador360 Development Engine To Enable Target Validation And Precision Medicine

JP Morgan analyst Elodie Rall maintains CRH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRH#NYSE">CRH</a>) with a Overweight and raises the price target from $114 to $116.

JP Morgan Maintains Overweight on CRH, Raises Price Target to $116

Baird analyst David Rescott maintains Medtronic (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MDT#NYSE">MDT</a>) with a Neutral and lowers the price target from $96 to $93.

Baird Maintains Neutral on Medtronic, Lowers Price Target to $93

Deloitte Announced An Expanded Collaboration With Hewlett Packard Enterprise, That Implements The Newly Launched Hpe Private Cloud Ai With Nvidia To Enhance Deloitte's Existing Ai Capabilities And Help Organizations Bring Generative Ai Solutions To Market Quickly

Earnings

TJX Companies Says Q3 Consolidated Comparable Store Sales Increased 3%, At The High-end Of The Company's Plan, And Were Entirely Driven By An Increase In Customer Transactions

Nano Dimension (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNDM#NASDAQ">NNDM</a>) reported quarterly losses of $(0.05) per share. This is a 80.77 percent increase over losses of $(0.26) per share from the same period last year. The company reported $14.86 million in sales this quarter. This is a 22.19 percent increase over sales of $12.16 million the same period last year.

NNDM

Nano Dimension Q3 EPS $(0.05) Up From $(0.26) YoY, Sales $14.86M Up From $12.16M YoY

For the full year Fiscal 2025, the Company continues to expect consolidated comparable store sales to be up 3%. The Company is increasing its outlook for pretax profit margin to be 11.3% and raising its diluted earnings per share outlook to be in the range of $4.15 to $4.17.

Guidance

TJX Companies Expects FY25 GAAP EPS Of $4.15-$4.17 Versus Prior Guidance Of $4.09-$4.13 And Consensus Of $4.16

Baird analyst Justin Kleber maintains Valvoline (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VVV#NYSE">VVV</a>) with a Outperform and lowers the price target from $48 to $46.

Baird Maintains Outperform on Valvoline, Lowers Price Target to $46

<ul>
<li>For the fourth quarter of Fiscal 2025, the Company continues to expect consolidated comparable store sales to be up 2% to 3%.&nbsp;</li>
<li>The Company now expects pretax profit margin to be in the range of 10.8% to 10.9% and diluted earnings per share to be in the range of $1.12 to $1.14.&nbsp;</li>
<li>The change in the Company's fourth quarter pretax profit margin and earnings per share guidance is due to the expected reversal of the third quarter benefit from the timing of certain expenses.</li>
</ul>

TJX Companies Expects Q4 FY25 GAAP EPS Of $1.12-$1.14 Versus Consensus Of $1.18

Baird analyst Timothy Wojs maintains Griffon (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GFF#NYSE">GFF</a>) with a Outperform and raises the price target from $92 to $100.

Comments

Odonate Inc

Odonate Inc (ODTCD) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO